Cargando…
Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review
BACKGROUND: Proton pump inhibitors (PPIs) are used worldwide for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). Although considered to be widely safe, PPIs have been associated with the potential risk of adverse effects such as infections including pneumonia...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440100/ https://www.ncbi.nlm.nih.gov/pubmed/30976431 http://dx.doi.org/10.1186/s40545-019-0167-0 |